Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Item
http://www.wikidata.org/entity/Q30235089
Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice.A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.The benefits of data mining.Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.Idiosyncratic drug-induced liver injury: A short review.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications.Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature.Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature.Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case ReportA Case of Acute Severe Hepatotoxicity and Mild Constriction of Common Bile Duct Associated With Ingestion of Green Tea Extract: A Clinical ChallengeProteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by DiclofenacIdiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature
P2860

Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Item
http://www.wikidata.org/entity/Q30235089
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@ast
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@en
type
label
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@ast
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@en
prefLabel
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@ast
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Drug-induced liver injury: recent advances in diagnosis and risk assessment.
@en
P2093
P2860
P304
P31
P356
10.1136/GUTJNL-2016-313369
P407
P433
P478
P50
P577
P698
P932